Evidence map›Paper›PMID 39210079›Full record

ArticleEJNMMI physics2024

Positronium lifetime validation measurements using a long-axial field-of-view positron emission tomography scanner.

William M Steinberger, Lorenzo Mercolli, Johannes Breuer, Hasan Sari, Szymon Parzych, Szymon Niedzwiecki, Gabriela Lapkiewicz, Pawel Moskal, Ewa Stepien, Axel Rominger and 2 more

Abstract read
In one paragraph

Article in EJNMMI physics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. High-Resolution Positronium Lifetime Tomography at Clinical Activity Levels on the PennPET Explorer.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

William M SteinbergerSiemens Medical Solutions USA, Inc., Knoxville, TN, 37932, USA. william.steinberger@siemens-healthineers.com.ORCID http://orcid.org/0000-0002-8293-5701
Lorenzo MercolliDepartment of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Johannes BreuerSiemens Healthineers AG, Forchheim, Germany.
Hasan SariSiemens Healthineers International AG, Zurich, Switzerland.
Szymon ParzychCenter for Theranostics, Institute of Physics, Jagiellonian University, ul. Lojasiewicza 11, 30-348, Krakow, Poland.
Szymon NiedzwieckiCenter for Theranostics, Institute of Physics, Jagiellonian University, ul. Lojasiewicza 11, 30-348, Krakow, Poland.
Gabriela LapkiewiczCenter for Theranostics, Institute of Physics, Jagiellonian University, ul. Lojasiewicza 11, 30-348, Krakow, Poland.
Pawel MoskalCenter for Theranostics, Institute of Physics, Jagiellonian University, ul. Lojasiewicza 11, 30-348, Krakow, Poland.
Ewa StepienCenter for Theranostics, Institute of Physics, Jagiellonian University, ul. Lojasiewicza 11, 30-348, Krakow, Poland.
Axel RomingerDepartment of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Kuangyu ShiDepartment of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Maurizio ContiSiemens Medical Solutions USA, Inc., Knoxville, TN, 37932, USA.

Funding

National Science Centre of Poland OPUS24+LAP No. 2022/47/I/NZ7/03112Swiss National Science Foundation 216944
6 · The paper itself

Abstract

backgroundPositron emission tomography (PET) traditionally uses coincident annihilation photons emitted from a positron interacting with an electron to localize cancer within the body. The formation of positronium (Ps), a bonded electron-positron pair, has not been utilized in clinical applications of PET due to the need to detect either the emission of a prompt gamma ray or the decay of higher-order coincident events. Assessment of the lifetime of the formed Ps, however, can potentially yield additional diagnostic information of the surrounding tissue because Ps properties vary due to void size and molecular composition. To assess the feasibility of measuring Ps lifetimes with a PET scanner, experiments were performed in a Biograph Vision Quadra (Siemens Healthineers). Quadra is a long-axial field-of-view (LA-FOV) PET scanner capable of producing list-mode data from single interaction events.

resultsOrtho-Ps (o-Ps) lifetimes were measured for quartz-glass and polycarbonate samples using a

conclusionOverall, the methodology presented in this manuscript demonstrates the repeatability of Ps lifetime measurements with clinically available isotopes in a commercially-available LA-FOV PET scanner. This validation work lays the foundation for future in-vivo patient scans with Quadra.

Indexed as

Molecular imagingPositron emission tomographyPositronium imaging

Identifiers

PMID39210079
PMCPMC11362402

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.